AGP Executive Report
Last update: 8 hours agoPatient Safety: The American Medical Association has launched a campaign urging patients to check online health advice with their doctors, as social media, search engines and AI chatbots spread misleading claims. New Treatment: The FDA authorized Theraclion’s Sonovein focused-ultrasound device for varicose veins. In a 70-person trial, it achieved 96.8% vein closure at one year, with no serious adverse events reported. Diabetes Technology: Tandem Diabetes Care won FDA clearance for its tubeless Mobi insulin-delivery system, with a U.S. launch planned for 2027. Biotech Deal: Eli Lilly will pay up to $1.5 billion for Calytrix Bio, whose experimental antibody targets rare blood cancers. Healthcare AI: A Menlo Ventures report says U.S. healthcare AI spending reached $3.7 billion, 2.5 times last year’s level, with investment growing rapidly in drug discovery and patient care.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.